Skip to content

Ayurvedic Chikitsa of Vataja Pinasa with Shodhana Basti and Nasya

A Role of Dosha Nirharana In The Management of Vataja Pinasa-A Comparative Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/08/015187
Enrollment
30
Registered
2018-08-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients suffering from vataja pinasa

Interventions

Intervention1: management of vataj pinasa with sakshar ghritapan, anutaila nasya and shodhana basti: 15 pts taken in one group and will be treated with shodhana basti in following dose and duration: s

Sponsors

Government Akhandanand Ayurveda Mahavidhyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Sign & Symptoms of Pakva vataja Pinasa 2.Basti yogya 3.Nasya yogya 4.Snehan yogya

Exclusion criteria

Exclusion criteria: 1.The person with age of 60years 2.Aamavstha of Vataja Pinasa :(The following lakshanas of Amavastha will be excluded in itâ??s excessive state.) Aruchi Mukha Vairasya Shirogurutva Kshvathu Ruja Arati Jwara Tanu Srava Sthivana Kshina Swara 3.Basti ayogya 4.Nasya ayogya 5.Snehana ayogya 6.Nasa Arsha 7.Nasa Arbuda

Design outcomes

Primary

MeasureTime frame
All the Sign and Symptoms of Vataja Pinasa will be assigned score depending upon their severity to assess the effect of the drugs at the time of before and after treatmnetTimepoint: 30 Days

Secondary

MeasureTime frame
All the sign and symptoms of vataja pinasa will be assigned score depending upon their severity to the effect of the drugs at the time of before and after treatmnetTimepoint: 30 Days

Countries

India

Contacts

Public ContactDr Krunal Chandana

Government Akhandanand Ayurveda Mahavidhyalaya

drhemangishukla@gmail.com9825504280

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026